Understanding IGF-1 and Heart Disease
Insulin-Like Growth Factor-1 and Atherosclerosis
This work explores how a natural substance called IGF-1 might help reduce plaque buildup in arteries and improve heart health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11109666 on NIH RePORTER |
What this research studies
Heart disease, often caused by plaque in arteries, remains a major health concern even with current treatments. This project looks at how a natural growth factor, IGF-1, could make these plaques more stable and less likely to cause problems. Researchers are studying how IGF-1 affects "senescent cells," which are old, damaged cells that contribute to plaque formation and thinning of the protective cap over plaques. By understanding this connection, we hope to find new ways to prevent serious heart events.
Who could benefit from this research
Good fit: Patients with coronary heart disease or those at high risk for atherosclerosis may eventually benefit from therapies developed from this research.
Not a fit: Patients without atherosclerosis or related heart conditions would likely not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that use IGF-1 to stabilize plaques and reduce the risk of heart attacks and strokes.
How similar studies have performed: Previous findings in mouse and pig models have shown that IGF-1 can reduce plaque burden and promote plaque stability.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Delafontaine, Patrice — Tulane University of Louisiana
- Study coordinator: Delafontaine, Patrice
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.